PNC Financial Services Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7K | Buy |
700
+21
| +3% | +$621 | ﹤0.01% | 3555 |
|
|
2025
Q1 | $20.3K | Buy |
679
+104
| +18% | +$3.11K | ﹤0.01% | 3532 |
|
|
2024
Q4 | $16.5K | Sell |
575
-337
| -37% | -$9.66K | ﹤0.01% | 3619 |
|
|
2024
Q3 | $35.2K | Buy |
912
+393
| +76% | +$15.2K | ﹤0.01% | 3258 |
|
|
2024
Q2 | $16.7K | Buy |
519
+4
| +0.8% | +$129 | ﹤0.01% | 3564 |
|
|
2024
Q1 | $20K | Buy |
515
+57
| +12% | +$2.21K | ﹤0.01% | 3447 |
|
|
2023
Q4 | $14.1K | Sell |
458
-123
| -21% | -$3.79K | ﹤0.01% | 3604 |
|
|
2023
Q3 | $13K | Buy |
581
+5
| +0.9% | +$112 | ﹤0.01% | 3641 |
|
|
2023
Q2 | $12.4K | Sell |
576
-3
| -0.5% | -$64 | ﹤0.01% | 3780 |
|
|
2023
Q1 | $13.9K | Buy |
579
+21
| +4% | +$504 | ﹤0.01% | 3654 |
|
|
2022
Q4 | $12.9K | Sell |
558
-21
| -4% | -$487 | ﹤0.01% | 3666 |
|
|
2022
Q3 | $9K | Buy |
579
+113
| +24% | +$1.76K | ﹤0.01% | 3801 |
|
|
2022
Q2 | $9K | Sell |
466
-1,758
| -79% | -$34K | ﹤0.01% | 3836 |
|
|
2022
Q1 | $44K | Buy |
2,224
+1,558
| +234% | +$30.8K | ﹤0.01% | 3180 |
|
|
2021
Q4 | $13K | Buy |
666
+337
| +102% | +$6.58K | ﹤0.01% | 3701 |
|
|
2021
Q3 | $6K | Sell |
329
-937
| -74% | -$17.1K | ﹤0.01% | 3872 |
|
|
2021
Q2 | $30K | Buy |
1,266
+900
| +246% | +$21.3K | ﹤0.01% | 3309 |
|
|
2021
Q1 | $8K | Buy |
+366
| New | +$8K | ﹤0.01% | 3700 |
|